Larry Biegelsen
Stock Analyst at Wells Fargo
(3.79)
# 665
Out of 4,893 analysts
310
Total ratings
53.74%
Success rate
6.79%
Average return
Main Sectors:
Stocks Rated by Larry Biegelsen
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| RXST RxSight | Downgrades: Equal-Weight | $25 → $9 | $8.09 | +11.25% | 14 | Jul 9, 2025 | |
| COO The Cooper Companies | Maintains: Overweight | $118 → $93 | $75.36 | +23.41% | 17 | May 30, 2025 | |
| MMSI Merit Medical Systems | Maintains: Overweight | $106 → $108 | $94.59 | +14.18% | 9 | May 21, 2025 | |
| HYPR Hyperfine | Maintains: Equal-Weight | $1.29 → $0.68 | $0.77 | -11.69% | 5 | May 14, 2025 | |
| ZBH Zimmer Biomet Holdings | Maintains: Equal-Weight | $113 → $98 | $94.35 | +3.87% | 10 | May 6, 2025 | |
| INSP Inspire Medical Systems | Maintains: Equal-Weight | $195 → $174 | $136.75 | +27.24% | 12 | May 6, 2025 | |
| TFX Teleflex | Maintains: Equal-Weight | $146 → $137 | $118.06 | +16.04% | 5 | May 2, 2025 | |
| BAX Baxter International | Maintains: Equal-Weight | $36 → $33 | $29.11 | +13.36% | 16 | May 2, 2025 | |
| BLCO Bausch + Lomb | Maintains: Equal-Weight | $15 → $12 | $14.04 | -14.50% | 6 | May 1, 2025 | |
| GEHC GE HealthCare Technologies | Maintains: Overweight | $103 → $89 | $75.43 | +17.99% | 4 | May 1, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $22 → $20 | $16.16 | +23.80% | 9 | May 1, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Equal-Weight | $160 → $86 | $105.22 | -18.26% | 14 | May 1, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $305 → $315 | $240.49 | +30.98% | 18 | Apr 24, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Overweight | $28 | $15.12 | +85.19% | 1 | Mar 31, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $100 → $118 | $103.23 | +14.31% | 13 | Feb 6, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $13 → $17 | $9.99 | +70.17% | 1 | Jan 30, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $427 → $435 | $391.24 | +11.18% | 15 | Jan 29, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $630 → $687 | $519.00 | +32.37% | 19 | Jan 24, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $166 → $152 | $156.18 | -2.68% | 13 | Jan 23, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $10 → $8 | $2.61 | +206.51% | 6 | Dec 11, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $90 → $94 | $84.41 | +11.36% | 9 | Dec 11, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $106 → $98 | $90.47 | +8.32% | 17 | Nov 20, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $90 → $80 | $77.58 | +3.12% | 15 | Sep 9, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $94 → $105 | $87.92 | +19.43% | 8 | Aug 22, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $42 → $40 | $18.15 | +120.39% | 17 | Jul 26, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Overweight | $40 → $49 | $12.88 | +280.43% | 2 | Dec 5, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $140 → $136 | $133.07 | +2.20% | 21 | Apr 5, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $80 → $70 | $57.19 | +22.40% | 7 | May 11, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $279 → $270 | $174.77 | +54.49% | 5 | Apr 8, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Outperform | n/a | $82.72 | - | 2 | Nov 2, 2017 |
RxSight
Jul 9, 2025
Downgrades: Equal-Weight
Price Target: $25 → $9
Current: $8.09
Upside: +11.25%
The Cooper Companies
May 30, 2025
Maintains: Overweight
Price Target: $118 → $93
Current: $75.36
Upside: +23.41%
Merit Medical Systems
May 21, 2025
Maintains: Overweight
Price Target: $106 → $108
Current: $94.59
Upside: +14.18%
Hyperfine
May 14, 2025
Maintains: Equal-Weight
Price Target: $1.29 → $0.68
Current: $0.77
Upside: -11.69%
Zimmer Biomet Holdings
May 6, 2025
Maintains: Equal-Weight
Price Target: $113 → $98
Current: $94.35
Upside: +3.87%
Inspire Medical Systems
May 6, 2025
Maintains: Equal-Weight
Price Target: $195 → $174
Current: $136.75
Upside: +27.24%
Teleflex
May 2, 2025
Maintains: Equal-Weight
Price Target: $146 → $137
Current: $118.06
Upside: +16.04%
Baxter International
May 2, 2025
Maintains: Equal-Weight
Price Target: $36 → $33
Current: $29.11
Upside: +13.36%
Bausch + Lomb
May 1, 2025
Maintains: Equal-Weight
Price Target: $15 → $12
Current: $14.04
Upside: -14.50%
GE HealthCare Technologies
May 1, 2025
Maintains: Overweight
Price Target: $103 → $89
Current: $75.43
Upside: +17.99%
May 1, 2025
Maintains: Equal-Weight
Price Target: $22 → $20
Current: $16.16
Upside: +23.80%
May 1, 2025
Downgrades: Equal-Weight
Price Target: $160 → $86
Current: $105.22
Upside: -18.26%
Apr 24, 2025
Maintains: Overweight
Price Target: $305 → $315
Current: $240.49
Upside: +30.98%
Mar 31, 2025
Initiates: Overweight
Price Target: $28
Current: $15.12
Upside: +85.19%
Feb 6, 2025
Maintains: Overweight
Price Target: $100 → $118
Current: $103.23
Upside: +14.31%
Jan 30, 2025
Maintains: Overweight
Price Target: $13 → $17
Current: $9.99
Upside: +70.17%
Jan 29, 2025
Maintains: Overweight
Price Target: $427 → $435
Current: $391.24
Upside: +11.18%
Jan 24, 2025
Maintains: Overweight
Price Target: $630 → $687
Current: $519.00
Upside: +32.37%
Jan 23, 2025
Maintains: Equal-Weight
Price Target: $166 → $152
Current: $156.18
Upside: -2.68%
Dec 11, 2024
Maintains: Equal-Weight
Price Target: $10 → $8
Current: $2.61
Upside: +206.51%
Dec 11, 2024
Maintains: Overweight
Price Target: $90 → $94
Current: $84.41
Upside: +11.36%
Nov 20, 2024
Maintains: Overweight
Price Target: $106 → $98
Current: $90.47
Upside: +8.32%
Sep 9, 2024
Maintains: Overweight
Price Target: $90 → $80
Current: $77.58
Upside: +3.12%
Aug 22, 2024
Maintains: Overweight
Price Target: $94 → $105
Current: $87.92
Upside: +19.43%
Jul 26, 2024
Maintains: Overweight
Price Target: $42 → $40
Current: $18.15
Upside: +120.39%
Dec 5, 2023
Upgrades: Overweight
Price Target: $40 → $49
Current: $12.88
Upside: +280.43%
Apr 5, 2023
Maintains: Overweight
Price Target: $140 → $136
Current: $133.07
Upside: +2.20%
May 11, 2022
Maintains: Overweight
Price Target: $80 → $70
Current: $57.19
Upside: +22.40%
Apr 8, 2020
Maintains: Overweight
Price Target: $279 → $270
Current: $174.77
Upside: +54.49%
Nov 2, 2017
Upgrades: Outperform
Price Target: n/a
Current: $82.72
Upside: -